Cvi2018 Session: A Challenging Case Of Bicuspid Aortic Stenosis - Allen C. Rassa Md

CVI2018 Session: Bicuspid Aortic Valve stenosis treated by TAVR - Ganesh Athappan, MD

Cardiovascular Innovations

CVI2018 Session: Structural Challenging Case Competition: Semifinals 1 (July 27, 13:30 pm)

Cardiovascular Innovations

CVI2018: Structural Challenging Case Competition: Semifinals 2 (Friday, July 27)

Cardiovascular Innovations

CVI2018 Session: Coronary Challenging Case Competition: Semifinals 1

Cardiovascular Innovations

CVI2018 Session: I wish you had sent this patient to surgery - S. Chris Malaisrie, MD

Cardiovascular Innovations

CVI2018 Session: Science and Needs for Aortic Valve Therapy

Cardiovascular Innovations

The Relationship Between Bicuspid Aortic Valve & the Aorta

Cleveland Clinic

CVI2018 Session: Rich Emotional Experiences in Aortic Valve Therapy (Mt. Sopris, July 26, 13:30 pm)

Cardiovascular Innovations

CVI2018 Session: The science of Sapien - Alan Zajarias, MD

Cardiovascular Innovations

ASK UNMC. I've told I have aortic stenosis. What is that and what are my treatment options?

CVI2018 Session: My most humbling TAVR case - Alan Zajarias, MD

Cardiovascular Innovations

The Difficult Case: What Do You Do with Poor Quality, Valve Quantification: AS versus MR

Evolut platform's aortic valve implantation in BIVOLUTX for bicuspid stenosis.

infocusrx today

Bicuspid Aortic Valve & Aneurysm Treatment: What Should Patients Know? (with Dr. William Brinkman)

HeartValveSurgery.com

CVI2018 Session: How I managed a difficult Sapien case - Samir Kapadia, MD

Cardiovascular Innovations

CVI2018 Session: CVI2018 Case Competition Finals (Colorado Ballroom, Saturday July 28, 12:30 pm)

Cardiovascular Innovations

Lifetime management of patients with aortic stenosis

PCR

BCIS ACI 2020: TAVI In The Treatment Of Symptomatic Aortic Stenosis — Dr Clare Appleby

Radcliffe Cardiology

CVI2018 Session: Live Structural Case from Cedars Sinai Medical Center (July 26, 3:30pm)

Cardiovascular Innovations

CVI2018 Session: Is there a problem with undertreatment with AVR? - Michael Reardon, MD

Cardiovascular Innovations